ArticleBMC sports science, medicine & rehabilitation2025
Twelve weeks of respiratory muscle training enhance respiratory function in CrossFit
Article in BMC sports science, medicine & rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06806124 (Analysis of Hematological Biomarkers, Muscle Respiratory Function and Sports Performance in CrossFit® Athletes Using the Elevation Training Mask 2.0 Upon Return to a High-intensity Training Program After Recovering from COVID-19. a Single-blind, Multicenter, Randomized Clinical Trial.), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Analysis of Hematological Biomarkers, Muscle Respiratory Function and Sports Performance in CrossFit® Athletes Using the Elevation Training Mask 2.0 Upon Return to a High-intensity Training Program After Recovering from COVID-19. a Single-blind, Multicenter, Randomized Clinical Trial.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe Elevation Training Mask 2.0 (ETM) is a respiratory muscle device, designed to simulate altitude training. It works by reducing airflow through a valve system. During exercise, ETM could restore respiratory damage from post-infection phase of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), allowing ventilatory restriction that works as resistance training for respiratory muscles.
aimTo comparatively evaluate the spirometry parameters in CrossFit
methodsIn a single-blind randomized clinical trial, following the Consolidated Standards of Reporting Trials (CONSORT) recommendations, 20 trained male athletes were randomly assigned to an EG and a CG using simulated ETM device. Both groups completed 12 weeks of CrossFit
resultsNo significant differences (p > 0.05) were observed comparing EG and CG in any of spirometry parameters evaluated. Nevertheless, significant differences (p < 0.05) in behavior were observed throughout the 36 training sessions for maximum voluntary ventilation (MVV) and maximum inspiratory pressure (MIP) with a strong effect (η²p = 0.693). In addition, significant improvements (p < 0.05) were observed in MIP and MVV exclusively in the EG when comparing T1 vs. T2.
conclusionThe findings suggest that the inclusion of ETM in a 12-week CrossFit PROTOCOL REGISTRATION: ClinicalTrials.gov, identifier (ID NCT06806124). 25/01/2025 retrospectively registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.